Skip to main content

WELLS FARGO & COMPANY/MN

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 72971 SAN FRANCISCO, CA

Position in RIGL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,131,726
+$857,278 QoQ
Shares Held
54,492
+15.6% QoQ
Ownership
0.292%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 73% Shared 0% None 27%

Common Shares in RIGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. RIGL ranks #96 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RIGL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,131,726 54,492
2026-03-31 $1,274,448 47,132
2025-12-31 $2,655,416 61,999
2025-09-30 $1,723,256 60,828
2025-06-30 $1,851,347 98,844
2025-03-31 $158,276 8,798
2024-12-31 $144,702 8,603
2024-09-30 $96,351 5,955
2024-06-30 $49,657 6,041
2024-03-31 $78,294 52,902
2023-12-31 $66,536 45,887
2023-09-30 $40,390 37,400
2023-06-30 $95,340 73,908
2023-03-31 $46,367 35,128
2022-12-31 $705 470
2022-09-30 $4,279 3,627
2022-06-30 $18,650 16,506
2022-03-31 $618,773 206,948
2021-12-31 $750,452 283,190
2021-09-30 $765,878 210,986
2021-06-30 $5,768,394 1,329,124
2021-03-31 $2,439,863 713,411
2020-12-31 $1,447,347 413,528
2020-09-30 $1,326,975 552,907
2020-06-30 $2,125,366 1,161,403
2020-03-31 $997,254 639,267